| Dataset | DGIdb Drug Targets 2026 |
| Category | physical interactions |
| Type | drug |
| Description | A carbamate ester that is the ethyl ester of [(1R,3aR,4aR,6R,8aR,9S,9aS)-9-{(E)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethynyl}-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl]carbamic acid. A protease-activated receptor-1 antagonist used (as its sulfate salt) for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or with peripheral arterial disease. It has been shown to reduce the rate of a combined endpoint of cardiovascular death, MI, stroke and urgent coronary revascularisation. (Chemical Entities of Biological Interest Ontology, CHEBI_82702) |
| External Link | https://dgidb.org/results?searchType=drug&searchTerms=VORAPAXAR |
| Similar Terms | |
| Downloads & Tools |
3 interacting proteins for the VORAPAXAR drug from theDGIdb Drug Targets 2026 dataset.
